tanshinone has been researched along with natriuretic peptide, brain in 1 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | tanshinone (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, B; Chen, N; Dong, D; Li, J; Li, X; Liu, Y; Lu, Y; Shan, H; Tan, X; Wang, G; Wang, X; Yang, B; Yang, F; Zhang, P | 1 |
1 other study(ies) available for tanshinone and natriuretic peptide, brain
| Article | Year |
|---|---|
Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Topics: Abietanes; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Signaling; Cardiomegaly; Drugs, Chinese Herbal; Isoproterenol; Medicine, Chinese Traditional; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; RNA, Messenger; Up-Regulation | 2011 |